跳至主要内容
临床试验/NCT03977779
NCT03977779招募中不适用

Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Institut Paoli-Calmettes2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2022年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
46
试验地点
2
主要终点
Percentage of patients with a complete clearance of the biodegradable stent

研究概览

简要总结

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age>18 years
  • Patients at risk of developing a Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis (procedure and/or patient-related risk factors

排除标准

  • Pregnant or breastfeeding women
  • Recent diagnosis (<1 month) of acute pancreatitis
  • contraindication to endoscopy
  • Hypersensitivity to indomethacine

结局指标

主要结局

Percentage of patients with a complete clearance of the biodegradable stent

时间窗: Day 15

The degradation of the stent will be evaluated both duodenoscopy/fluoroscopy and endoscopy 15 days after its placement

次要结局

未报告次要终点

研究者

发起方
Institut Paoli-Calmettes
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验